Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | GAA | P10253 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11741238 | 0.97 | LMNA (0.70) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL8166873 | 0.88 | LMNA (0.61) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL14869406 | 0.88 | LMNA (0.61) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL821681 | 0.88 | LMNA (0.61) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL10651511 | 0.86 | LMNA (0.58) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL11788142 | 0.86 | LMNA (0.58) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL4124952 | 0.86 | LMNA (0.58) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL5011028 | 0.86 | LMNA (0.58) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| SCHEMBL2623096 | 0.86 | LMNA (0.58) | LMNAGAACYP1A2CYP2C19L3MBTL1 | |
| Simazine SCHEMBL8409822 | 0.86 | LMNA (1.00) | LMNAGAACYP1A2CYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0493788-B1 | Three-layer vascular prosthesis | MUDR MILAN KRAJICEK CSC (CS) | 1996-09-25 | — | — | EP | claimed |
| EP-0493788-A1 | Three-layer vascular prosthesis | MUDR. MILAN KRAJICEK CSc. (CS) | 1992-07-08 | — | — | EP | claimed |
| CN-119015258-A | Nucleic acid mediated delivery of therapeutic agents | 加利福尼亚大学董事会 | 2024-11-26 | — | — | CN | disclosed |
| CN-110325543-B | Cyclic dinucleotides as STING (stimulator of interferon genes) agonists | 武田药品工业株式会社 | 2023-03-31 | — | — | CN | disclosed |
| CN-110896605-B | Use of compounds for the preparation of a medicament for the prevention, treatment or amelioration of pain | 深圳艾欣达伟医药科技有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-114746753-A | Correlating AKR1C3 enzyme expression level through prostaglandin content and screening administration application | 深圳艾欣达伟医药科技有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-114555614-A | Anti-cancer compounds as non-PGP substrates | 深圳艾欣达伟医药科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-11044912-B2 | Branched polymeric biguanide compounds and their uses | CHEN HWANG HSING (US) | 2021-06-29 | — | — | US | disclosed |
| US-10843967-B2 | Road and surface coating compositions and processes thereof | ePave, LLC (US) | 2020-11-24 | — | — | US | disclosed |
| EP-3544963-B1 | METHOD FOR ALKYLATING AN AMINO COMPOUND | BOREALIS AGROLINZ MELAMINE (AT) | 2020-11-04 | — | — | EP | disclosed |
| EP-3544963-B1 | METHOD FOR ALKYLATING AN AMINO COMPOUND | BOREALIS AGROLINZ MELAMINE (AT) | 2020-11-04 | — | — | EP | disclosed |
| US-6127538-A | HYDROXYALKYLATION OF A TRIAMINO TRIAZINE DERIVATIVE HAVING AT LEAST ONE REACTIVE NITROGEN BY REACTING WHILE HEATING WITH AN ALKANEDIOL OR ITS ADDUCT IN THE PRESENCE OF HYDROGEN AND A METAL CATALYST; BY-PRODUCT INHIBITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-10-03 | — | — | US | disclosed |
| US-6124381-A | CURING ACCELERATOR IS A 2-((MONO- OR DI-ALKYL)AMINO, MORPHOLINO, PIPERIDINO, METHYL OR PHENYL)-4,6-SUBSTITUTED DIAMINO-1,3,5-TRIAZINE OF GIVEN FORMULA; POT LIFE, STORAGE STABILITY, AND WORKABILITY | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-09-26 | — | — | US | disclosed |
| EP-0882720-A1 | METHODS FOR MODIFYING 1,3,5-TRIAZINE DERIVATIVES | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1998-12-09 | — | — | EP | disclosed |
| US-5792867-A | Method of alkylating of triazine derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0834523-A1 | EPOXY/ACID ANHYDRIDE COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1998-04-08 | — | — | EP | disclosed |
| EP-0711760-A1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |
| EP-0006206-B1 | MELAMINE GROUP-CONTAINING ACRYLATES AND/OR METHACRYLATES, POLYMERIZABLE AND CURABLE COMPOSITION THEREOF, MOLDED ARTICLE MADE OF THE POLYMERIZED AND CURED COMPOSITION AND RESIN MOLDED ARTICLE COATED WITH THE COMPOSITION | TEIJIN LIMITED (JP) | 1982-11-24 | — | — | EP | disclosed |
| US-4186265-A | BY EXTRACTION WITH AQUEOUS ACID OR BY ACIDIFICATION OF ALKALINE FILTRATE FOLLOWED BY EXTRACTION WITH WATER-IMMISCIBLE SOLVENT | CIBA-GEIGY CORPORATION (US) | 1980-01-29 | — | — | US | disclosed |
| US-3988292-A | A TRIAZINE DERIVATIVE | TEIJIN LIMITED (JA) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11044912-B2 | Branched polymeric biguanide compounds and their uses | PUF60, XRCC6, PCNA | LMNA 2310/4885GAA 127/4885CYP1A2 1462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.